CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 25,871 enrolled
Drug / intervention
Fish Oil +2 moredrug
Likely dose
Fish Oil 465 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01351805
NCT01351805N/ACompleted

Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain

Brigham and Women's Hospital·interventional·Posted May 11, 2011·Updated Dec 3, 2025

In Brief

A clinical study evaluating Fish Oil, Vitamin D, and 1 other intervention for Autoimmune Diseases and 4 related conditions. Completed, enrolled 25,871 participants across 1 site.

Detailed Summary

The VITamin D and OmegA-3 TriaL (VITAL; NCT 01169259) is a randomized clinical trial in 25,871 U.S. men and women investigating whether taking daily dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor® fish oil, 1 gram) reduces the risk of developing cancer, heart disease, and stroke in people who do not have a prior history of these illnesses. This ancillary study is being conducted among VITAL participants and will examine whether vitamin D or fish oil have effects upon A) autoimmune disease incidence, B) biomarkers of systemic inflammation, and C) chronic knee pain. Blood samples at baseline and in follow-up will be collected in a randomly selected subcohort of 1500 individuals and analyzed for changes in biomarkers of systemic inflammation: C-reactive protein, interleukin-6, and tumor necrosis factor-receptor 2. Approximately 1300 individuals with chronic, frequent knee pain will be followed with annual questionnaires to evaluate the effects of the supplements on chronic knee pain.

Study Details

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedMay 11, 2011
Enrollment StartJul 1, 2010
Primary CompletionNov 10, 2018
Study CompletionFeb 1, 2025
TodayJul 2, 2026
Enrollment to primary: 8.4 yearsPosted 15.1 years ago

Interventions

Fish Oildrug

Subjects will receive marine omega-3 fatty acids (465 mg of eicosapentaenoic acid \[EPA\] and 375 mg of docosahexaenoic acid \[DHA\]).

Vitamin Ddietary

Subjects will receive vitamin D3 (cholecalciferol) 2000 IU a day.

placebo pillother

placebo